Around 3–7% of NSCLC cases present active ALK rearrangement (ALK+ NSCLC) that produces an abnormal activity of the ALK protein cell signaling pathway and causes the cancer cells to grow and metastasize [5, 6]. This evidence concerns the gene ALK and non-small cell lung carcinoma.